Børsen
Novo Nordisk has gotten off to a good start with its weight loss pill, and the initial demand leads the CEO to see a future where pills can dominate the market.
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?